Q-Line Biotech Limited develops, manufactures, and markets various reagents and consumables in India and internationally. It offers reagent kits, rapid cards, consumables, and point-of-care strips for applications in immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, and others, as well as in vitro testing of human samples, supporting disease prediction, prevention, diagnosis, monitoring, and health status evaluation. The company also provides diagnostic equipment comprising analyzers, point-of-care devices, and other critical components for diagnostic procedures; medical equipment maintenance services; and trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables. In addition, it offers Selectra Pro M, an automatic clinical chemistry analyzer. Further, the company develops Selectra Pro XL, an automatic clinical chemistry analyzer for large laboratories and hospital networks; Mircolab 300, a semi-au
| Current Price | ₹549.05 |
|---|---|
| Market Cap | ₹1,268 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Health Care; Health Care Equipment and Services; Health Care Equipment and Supplies; Health Care Supplies; Medical Consumables; Bandages |
| P/E Ratio | 15.8 |
| Beta (1Y) | 1.57 |
1. Manufacturing-67.4% 2. Trading-32.6%
Q-Line Biotech Limited is trading at ₹549.05, with a market capitalisation of ₹1,268 Cr.
Q-Line Biotech Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Health Care; Health Care Equipment and Services; Health Care Equipment and Supplies; Health Care Supplies; Medical Consumables; Bandages).
Q-Line Biotech Limited has a P/E of 15.8.